Other research showed that a concentration-dependent dose reduces EGFR phosphorylation by inducing EGFR degradation and suppressing cell proliferation in various gefitinib-resistant non-small-cell lung carcinoma cell lines [64]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.